Form 8-K - Current report:
SEC Accession No. 0000950170-25-037260
Filing Date
2025-03-11
Accepted
2025-03-11 16:54:00
Documents
11
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K gern-20250310.htm   iXBRL 8-K 46721
  Complete submission text file 0000950170-25-037260.txt   164121

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20250310.xsd EX-101.SCH 27898
13 EXTRACTED XBRL INSTANCE DOCUMENT gern-20250310_htm.xml XML 4697
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 25728381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)